Skip to main content
. 2021 May 24;36(4):713–726. doi: 10.1007/s10557-021-07186-y

Fig. 4.

Fig. 4

The drug-target-disease networks of SGLT2 inhibitors and diabetes status with heart failure. The yellow nodes represent DM and HF; the green nodes represent four SGLT2 inhibitors; the pink nodes represent 125 common targets.